+1 915 229 3004 (U.S.) | 
+44 7452 242832 (U.K.)
+1 915 229 3004 (U.S.) | +44 7452 242832 (U.K.)
America Orthopedic Biomaterial Market Size was valued at USD 0.6 Billion in 2022. The America Orthopedic Biomaterial Market industry is projected to grow from USD 0.74 Billion in 2023 to USD 0.8 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 12.50% during the forecast period (2023 - 2032). Sports-related, accident-, fall-, and injury-related injuries, as well as chronic bone diseases and musculoskeletal disorders, are all on the rise, are the key market drivers enhancing the market growth.
Download Free Sample to learn more about this report
Source: Secondary Research, Primary Research, RESEARCH LAYER Database and Analyst Review
Chronic skeletal issues and musculoskeletal illnesses are becoming more common, which is propelling market growth and boosting consumer demand for goods. The need is expected to expand as a result of the aging population, which is more vulnerable to chronic diseases. For instance, the U.S. Census Bureau says that 1.6 million more people aged 65 and older were present in 2015 compared to 2014. The rise in trauma cases from sports, accidents, and falls is another factor influencing the demand for orthopaedic biomaterials. With more people engaging in sport and leisure activities, injury risk is increasing.
National Health Statistics Reports estimate that 213 million Americans aged 6 and older engaged in sports and fitness activities in 2015, up from 209 million in 2014. An increase in orthopaedic operations such as viscosupplementation, joint reconstruction, and joint arthroplasty is also contributing to the growth of this industry. Additionally, there is a growing need worldwide for next-generation orthopaedic biomaterials, which are created particularly to meet the needs of a given orthopaedic operation. On the other hand, the market's growth has been constrained by the limited options for payment coverage for these products and the declining reimbursement for orthopaedic implants in a number of countries. Additionally, the lack of reimbursements forced vendors to lower their prices, which restrained the market's growth.
The market is anticipated to be impacted by the aging of the population, an increase in the frequency of musculoskeletal injuries, and a growth in the number of patients choosing knee replacement, joint reconstruction, and other orthopaedic surgery involving joints. According to the UN Department of Economic and Social Affairs' World Population Prospects 2022 study, the percentage of individuals 65 and older will increase from 10% in 2022 to 16% in 2050. The number of people 65 and older is predicted to surpass that of children under the age of five by the year 2050 and will be almost equal to that of children under the age of twelve. Orthopaedic biomaterials are expected to be used increasingly frequently over the next years as the world's aging population becomes more vulnerable to joint issues and surgeries. Injuries to the musculoskeletal system affect 1.71 billion individuals globally, according to data from the World Health Organization from July 2022. The market for orthopaedic biomaterials is expanding as a result of the increasing prevalence of musculoskeletal injuries brought on by such a high burden of musculoskeletal disorders. Thus, driving the America Orthopedic Biomaterial Market revenue.
The America Orthopedic Biomaterial Market segmentation, based on Type of Material, includes metal, non-metal, and others. Non-metal segment accounted for the largest revenue share in 2022. The increasing use of ceramics in numerous methods for the restoration of hard tissues is to blame for this. However, the others category is anticipated to grow at the fastest rate over the projection period because to the extensive usage of polymers as bone cement and load-bearing surfaces for total joint arthroplasties. The availability of advanced polymers and biopolymers for a range of applications, including orthobiologic and bio-resorbable tissue fixation, has raised the demand for polymers internationally.
The America Orthopedic Biomaterial Market segmentation, based on Application, includes joint replacement, fracture fixation devices, tissue fixation, spine implants, viscosupplementation, and others. Joint replacement segment dominated the America Orthopedic Biomaterial Market in 2022. The market for these products is expected to see an increase in demand due to an increase in bone fractures, disc degenerative disorders, and trauma cases. The fracture fixation devices market is predicted to expand at the fastest rate over the forecast period as a result of the increased number of bone repair and reconstruction surgeries conducted globally as a consequence of an increase in obesity and trauma cases. Around 1.3 million people worldwide pass away as a result of traffic accidents each year, according to estimates made public by the WHO, with 93% of all road fatalities occurring in low- and middle-income countries.
Download Free Sample to learn more about this report
Source: Secondary Research, Primary Research, RESEARCH LAYER Database and Analyst Review
Insights into the markets in North America, Europe, Asia-Pacific, and the rest of the world are provided by the study. The North America America Orthopedic Biomaterial Market dominated this market in 2022 (45.80%). This expansion can be attributed to the rise in patients needing orthopaedic surgery such as knee replacement, reconstruction, and others. The regional market is expected to grow even more as a result of the quick uptake of cutting-edge devices for implant load-bearing and bone gap filling. Further, In the North American area, the U.S. Orthopedic Biomaterial market had the biggest market share, while the Canada Orthopedic Biomaterial market had the quickest rate of expansion.
The market for North American orthopaedic biomaterials was dominated by the United States. A considerable portion of the elderly population in the United States is predisposed to musculoskeletal conditions like osteoarthritis and osteoporosis. The demand for orthopaedic biomaterials has been driven by the rising occurrence of these illnesses.
In terms of market share for orthopaedic biomaterials in North America, Canada came in second. Orthopaedic biomaterials are among the areas of healthcare research and development that the Canadian government has been actively pushing. Market expansion has been fueled by funding and programmes meant to foster cutting-edge technologies.
Download Free Sample to learn more about this report
Source: Secondary Research, Primary Research, RESEARCH LAYER Database and Analyst Review
Leading industry companies are making significant R&D investments in order to diversify their product offerings, which will drive the Orthopedic Biomaterial market's expansion. Important market developments include new product releases, contractual agreements, mergers and acquisitions, greater investments, and collaboration with other organizations. Market participants are also engaging in a number of strategic actions to increase their global footprint. The Orthopedic Biomaterial sector needs to provide affordable products if it wants to grow and thrive in a more competitive and challenging market environment.
One of the primary business strategies employed by manufacturers in the worldwide Orthopedic Biomaterial industry to assist customers and expand the market sector is local manufacturing to reduce operational costs. Some of the biggest benefits to medicine have recently come from the Orthopedic Biomaterial sector. Major players in the America Orthopedic Biomaterial Market, including Materion Corporation, Carpenter Technology Corporation, Ulbrich Stainless Steel & Special Metals, Inc., CeramTec, Ceradyne, Heraeus Medical Components, Kyocera Corporation, Ticona GmbH, Purac Biomaterials, Acumed, Amedica Corporation, Johnson & Johnson, Osteotech, Inc., Cam Bioceramics B.V., and Landec Corporation, are attempting to increase market demand by investing in research and development operations.
RAG-Stiftung is the owner of the specialty chemical business Evonik Industries AG (Evonik). Surfactants, polymers, resins, and additives are just a few examples of the diverse spectrum of chemicals that are included in its product line. Agriculture, alternative energy, paints and coatings, paper and printing, metal and oil products, electrical and electronics, food and animal feed, personal care and cosmetics, pharmaceuticals, plastics and rubber, automotive, and construction are just a few of the industries that use the company's products. Services in engineering, logistics, utilities, and process technologies are also available. Significant production facilities are operated by Evonik in China, Singapore, Belgium, the US, and Germany. In addition to the Americas, the corporation has a presence in Asia-Pacific, Africa, South America, and Europe. The corporate headquarters of Evonik are in Essen, North Rhine-Westphalia, Germany. Osteoconductive VESTAKEEP Fusion PEEK filament, a material for 3D-printed implants, was announced by Evonik in March 2022.
Orthofix Medical Inc. (Orthofix), a producer of medical equipment, formerly known as Orthofix International NV, provides reconstructive and regenerative musculoskeletal solutions to medical professionals everywhere. The company's major products include those for managing fractures, regenerative goods and tissue forms, paediatrics and limb reconstruction, mobility preservation and fixation implant devices, and foot and ankle products. Orthofix offers its products both directly and through a network of distributors in order to reach hospitals, physicians, integrated health delivery systems, ambulatory surgery centers, and other purchasing organizations across the world. It also has facilities there, in addition to the US, UK, Brazil, Italy, France, and Germany. Based in Lewisville, Texas, Orthofix is a company with US operations. Orthofix Medical released Opus BA in February 2022, a combination of carbonate apatite bone mineral, bioactive glass, and Type 1 collagen carrier for cervical and lumbar spine fusion procedures.
· Materion Corporation
· Carpenter Technology Corporation
· Ulbrich Stainless Steel & Special Metals, Inc.
· CeramTec
· Ceradyne
· Heraeus Medical Components
· Kyocera Corporation
· Ticona GmbH
· Purac Biomaterials
· Acumed
· Amedica Corporation
· Johnson & Johnson
· Osteotech, Inc.
· Cam Bioceramics B.V.
· Landec Corporation
March 2022: Synergy Biomedical, LLC, a manufacturer of advanced biomaterial products, unveiled BIOSPHERE FLEX SP EXTREMITIES, a synthetic bioactive bone graft. The sheet putty known as BIOSPHERE FLEX SP Extremities is composed of a spherical bioactive glass and a porous collagen/sodium hyaluronate carrier.
· Metal
· Non-Metal
· Others
· Joint Replacement
· Fracture Fixation Devices
· Tissue Fixation
· Spine Implants
· Viscosupplementation
· Others
· North America
- US
- Canada
· Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
· Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Australia
- Rest of Asia-Pacific
· Rest of the World
- Middle East
- Africa
- Latin America
|
Report Attribute/Metric |
Details |
|
Market Size 2022 |
USD 0.6 Billion |
|
Market Size 2023 |
USD 0.74 Billion |
|
Market Size 2032 |
USD 0.8 Billion |
|
Compound Annual Growth Rate (CAGR) |
12.50% (2023-2032) |
|
Base Year |
2022 |
|
Market Forecast Period |
2023-2032 |
|
Historical Data |
2018- 2022 |
|
Market Forecast Units |
Value (USD Billion) |
|
Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
|
Segments Covered |
Type of Material, Application, and Region |
|
Geographies Covered |
North America |
|
Countries Covered |
The U.S., Canada, German, France, U.K, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
|
Key Companies Profiled |
Materion Corporation, Carpenter Technology Corporation, Ulbrich Stainless Steel & Special Metals, Inc., CeramTec, Ceradyne, Heraeus Medical Components, Kyocera Corporation, Ticona GmbH, Purac Biomaterials, Acumed, Amedica Corporation, Johnson & Johnson, Osteotech, Inc., Cam Bioceramics B.V., and Landec Corporation |
|
Key Market Opportunities |
Technological advancements |
|
Key Market Dynamics |
Increasing incidence of musculoskeletal ailments and chronic skeletal conditions and rise in the number of trauma cases arising from accidents, fall, and sports |
The America Orthopedic Biomaterial Market size was valued at USD 0.6 Billion in 2022.
The market is projected to grow at a CAGR of 12.50% during the forecast period, 2023-2032.
Canada had the largest share in the market
The key players in the market are Materion Corporation, Carpenter Technology Corporation, Ulbrich Stainless Steel & Special Metals, Inc., CeramTec, Ceradyne, Heraeus Medical Components, Kyocera Corporation, Ticona GmbH, Purac Biomaterials, Acumed, Amedica Corporation, Johnson & Johnson, Osteotech, Inc., Cam Bioceramics B.V., and Landec Corporation
The Non-Metal Type of Material dominated the market in 2022.
The Joint Replacement Application had the largest share in the market.
Research on the market is done by industry professionals who provide personalized insights on the industry structure, market segmentation, Type assessment, competitive landscape (CL), along with penetration, and emerging trends. In addition to years of professional experience in their various fields and sectors, their analysis is largely based on primary interview (60%) and secondary research (40%) as well as years of professional experience. In addition, our researchers forecast the market's direction over the following seven years by examining past trends and the market's current position. Additionally, various trends of segments and categories that are geographically portrayed are studied and estimated using primary and secondary research.
The key level executives (VP, CEO, Marketing Directors, and Business Development Managers) of the major industry participants who are active and prominent as well as mid-scale businesses operating in this market were interviewed in-depth for this supply-side report by overall Global Market Research.
Extensive primary research was conducted to gain a deeper grasp of the market and industry. Both primary and secondary research, as well as years of pertinent professional experience, are used to support the analysis. By analyzing past and present market patterns, our experts were able to forecast the market's course over the following seven years. For the geographically offered categories in the list of market tables, it differs per category. In connection with the Global Market research report, we also conducted a number of primary interviews with senior level executives (VP, CEO's, Directors, Marketing Directors, Business Development Managers, CFOs, Technical Consultants, Key Opinion Leaders, Industry Experts, Decision Matrix Authorities, and other crucial individuals) of the key industry players who dominated the Global market.
The primary purpose of secondary research was to gather, identify, and validate the information necessary for the thorough, technical, market-focused, and commercial analysis of the global market. With the use of this study, it was also possible to classify and segment the market in accordance with market trends, geographic markets, and regional considerations linked to market type. Analysts have gathered data in the Distribution Channel for the study of the market from reliable sources including annual reports, journals, white papers, corporate presentations, company websites, international organizations of Energy and Power manufacturers, credible paid databases, and many others to gather reliable intel.
Both top-down and bottom-up methodologies were employed to assess the accuracy of the global market size. The market for as a whole was estimated using these methods for a number of different dependent submarkets. Secondary research was used to address the major industry players, and primary and secondary research was used to calculate their market shares in the various regions. This complete intellectual process includes reading the annual and financial reports of the top market participants and conducting in-depth interviews with top industry executives (VP, CEO, Marketing Directors, and Business Development Managers) to gain important industry insights.
Through reliable secondary sources and validated primary sources, the classification of the global markets and their geographic percentage splits were established. To obtain the final qualitative and quantitative data, all relevant variables that might have an impact on the market under investigation have been taken into consideration, inspected in great depth, verified through primary research, and assessed. This information was collected, added to, and thoroughly examined by professional analysts before being provided in this report. The process used to estimate the overall market size for this study is depicted in the following image as an example.
Report Code :
RL65332
Published on :
Sep 2023
Request a Free Sample Report
Speak to Analyst